4.UNCAN.eu A Coordination and Support Action to prepare UNCAN.eu platform
- Coordinator
- Institut National De La Sante Et De La Recherche Medicale, France
- Runs
- 1 September 2022 to 30 November 2023
- Status
- Running
- EU funding
- €3.0m
- Total cost
- €3.0m
- Partners
- 31 organisations in 20 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101069496
What the project is doing
In the project's own words, from its summary on CORDIS.
The 15-month coordination and support action “4.UNCAN.eu” will generate a strategic agenda to launch UNCAN.eu, a European initiative to UNderstand CANcer proposed by the Mission Board and the European Beating Cancer Plan. This research agenda will be built with the final aim of achieving a new breakthrough in cancer prevention and treatment that will contribute to saving European citizens’ lives and help ensuring an optimal quality of life to disease survivors.
To reach a new level of understanding, UNCAN.eu will take advantage of recent advances in research data generation and data sciences. Reliable, high-quality cancer research data generated by experimental model analysis and collected from longitudinal follow-up of cancer patients will be shared and integrated at an unprecedented scale within a Federated Cancer Research data hub, in the context of the General Data Protection Regulation.
This information will be used by relevant players in Europe and beyond to address urgent and essential scientific and medical challenges in cancer prevention, early diagnosis, treatment and survivorship, in males and females of various ages. These challenges, identified in close interaction with European patients and citizens, will be tackled through competitive, ambitious and innovative, cross-border and trans-disciplinary research programmes built in a problem-solving manner.
The definition of challenges will integrate inequalities in cancer research across regions and member states in order to boost the research potential of less-developed regions in Europe. Players will be committed to open science principles, including FAIR (findable, accessible, interoperable, and reusable) guiding principles for scientific data collection, management and stewardship. The new understanding gained from the collection and analysis of this wealth of data will apply secondarily to other diseases.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Coordinator |
| Medizinische Universitaet Wien | Wien | Austria | Participant |
| European Cancer Patient Coalition | Bruxelles / Brussel | Belgium | Participant |
| Organisation of European Cancer Institutes | Bruxelles / Brussel | Belgium | Participant |
| Sciensano | Elsene | Belgium | Participant |
| Siop Europe | Bruxelles / Brussel | Belgium | Participant |
| Masarykuv Onkologicky Ustav | Brno | Czechia | Participant |
| Deutsches Krebsforschungszentrum Heidelberg | Heidelberg | Germany | Participant |
| Region Nordjylland (north Denmark Region) | Aalborg | Denmark | Participant |
| Tartu Ulikool | Tartu | Estonia | Participant |
| Consorcio Centro De Investigacion Biomedica En Red M.p. | Madrid | Spain | Participant |
| Fundacio Privada Institut D'investigacio Oncologica De Vall-Hebron (vhio) | Barcelona | Spain | Participant |
| Helsingin Yliopisto | Helsinki | Finland | Participant |
| Centre International De Recherche Sur Le Cancer | Lyon 7eme | France | Participant |
| Inserm Transfert SA | Paris | France | Participant |
| Institut National Du Cancer Gip | Boulogne Billancourt | France | Participant |
| Universite Paris-Saclay | Gif-Sur-Yvette | France | Third party |
| Orszagos Onkologiai Intezet | Budapest | Hungary | Participant |
| University College Dublin, National University of Ireland, Dublin | Dublin | Ireland | Participant |
| Alleanza Contro Il Cancro | Roma | Italy | Participant |
| Vilniaus Universiteto Ligonine Santaros Klinikos | Vilnius | Lithuania | Participant |
| Luxembourg Institute of Health | Strassen | Luxembourg | Participant |
| Office of the Deputy Prime Minister and Ministry for Health | Valletta | Malta | Participant |
| Childhood Cancer International | Amsterdam | Netherlands | Participant |
| Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis | Amsterdam | Netherlands | Participant |
| Stichting Integraal Kankercentrum Nederland | Utrecht | Netherlands | Third party |
| Stichting Oncode Institute | Utrecht | Netherlands | Participant |
| Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie -Panstwowy Instytut Badawczy | Warszawa | Poland | Participant |
| Instituto Portugues De Oncologia Do Porto Francisco Gentil, Epe | Porto | Portugal | Participant |
| Kemijski Institut | Ljubljana | Slovenia | Participant |
| Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna Institucia | Bratislava | Slovakia | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI